Formulation optimization of controlled delivery system for antihypertensive peptide using response surface methodology

American Journal of Drug Discovery and Development

Volumn 1, Issue 3, 2011, Pages 174-187

  Singh, Manju Rawat ^a   Singh, Deependra ^a   Saraf, Swarnlata ^a  

^a PT RAVISHANKAR SHUKLA UNIVERSITY   (India)

Author keywords

Box behnken design; Eudragit S100; Experimental designing; Microspheres; Optimization; Water soluble polypeptide

Indexed keywords

ENALAPRIL MALEATE; EUDRAGIT; MICROSPHERE; POLYSORBATE 80;

ANALYTICAL PARAMETERS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STRUCTURE; ENCAPSULATION; EXPERIMENTAL DESIGN; IN VITRO STUDY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; RESPONSE SURFACE METHOD;

EID: 79959589511     PISSN: 2150427X     EISSN: 21504296     Source Type: Journal    
DOI: 10.3923/ajdd.2011.174.187     Document Type: Article

References (33)

1. Abdel-Salam, O.M.E., N.S. Hassan, A.R. Baiuomy and S.H. Karam, 2007. The effect of amlodipine, diltiazem and enalapril on hepatic injury caused in rats by the administration of CC14. J. Pharmacol. Toxicol., 2: 610-620.
2. Ahlin, P., J. Kristl, A. Kristl and F. Vreer, 2002. Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration. Int. J. Pharm., 239: 113-120.
3. Al-Omari, M.M., M.K. Abdelah, A.A. Badwan and A.M.Y. Jaber, 2001. Effect of the drug-matrix on the stability of enalapril maleate in tablet formulations. J. Pharm. Biomed. Anal., 25: 893-902.
4. Benita, S., 1996. Microencapsulation: Methods and Industrial Applications. Marcel Dekkar, New York.
5. Brannon-Peppas, L. and M. Vert, 2000. Polylactic and Polyglycolic Acid Acids as Drug Carriers. In: Handbook of Pharmaceutical Controlled Release Technology. Wise, D.L. (Ed.). Marcel Dekker, Inc., New York, pp: 99-130.
6. De Rosa, G., R. Iommelli, M.I. La Rotonda, A. Miro and F. Quaglia, 2000. Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres. J. Control. Rel., 69: 283-295.
7. Denkbas, E.B., M. Seyyal and E. Piskin, 1999. 5-fluorouracil loaded chitosan microspheres for chemoembolization. J. Microencapsulation, 16: 741-749.
8. Dredan, J., I. Antal and I. Racz, 1996. Evaluation of mathematical models describing drug release from lipophilic matrices. Int. J. Pharm., 145: 61-64.
9. Gombotz, W.R. and D.K. Pettit, 1995. Biodegradable polymers for protein and peptide drug delivery. Bioconjugate Chem., 6: 332-351.
10. Ito, F., H. Fujimori and K. Makino, 2007. Incorporation of water-soluble drugs in PLGA microspheres. Coll. Surf. B Biointerfaces, 54: 173-178.
11. Jain, D., A.K. Panda and D.K. Majumdar, 2005. Eudragit S100 entrapped insulin microspheres for oral delivery. AAPS PharmSciTech, 6: E100-E107.
12. Kirn, D.D., M.M. Takeno, B.D. Ratner and T.A. Horbett, 1998. Glow discharge plasma deposition (GDPD) technique for the local controlled delivery of hirudin from biomaterials. Pharm. Res., 15: 783-786.
13. Moncloa, F., J.A. Sromovsky, J.F. Walker and R.O. Davies, 1985. Enalapril in hypertension and congestive heart failure. Overall review of efficacy and safety. Drugs, 30: 82-89.
14. Niwa, T., H. Takeuchi, T. Hino, N. Kunuo and Y. Kawashima, 1994. In vitro drug release behavior of D, L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method. J. Pharm. Sci., 83: 727-732.
15. Parashar, V., D. Ahmad, S.P. Gupta, N. Upmanyu, N. Parashar and V. Mudgal, 2010. Formulation and evaluation of biodegradable microspheres of tinidazole. Int. J. Drug Delivery, 2: 238-241.
16. Peppas, N.A., 1985. Analysis of fickian and non-fickian drug release from polymers. Pharm. Acta Helv, 60: 110-111.
17. Rawat, M. and S. Saraf, 2007. Influence of selected formulation variables on the preparation of enzyme-entrapped eudragit S100 microspheres. AAPS PharmSciTech., 8: 289-297.
18. Rawat, M. and S.S. Reader, 2009. Formulation optimization of double emulsification method for preparation of enzyme-loaded Eudragit S100 microspheres. J. Microencapsulation, 26: 306-314.
19. Rawat, M., Singh D., Saraf S. and S. Swarnlata, 2008. Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme. Drug Dev. Ind. Pharm, 34: 181-188.
20. Reithmeier, H., J. Herrmann and A. Gopferich, 2001. Lipid mi crop articles as a parenteral controlled release device for peptides. J. Control Rel., 73: 339-350.
21. Rudra, A., K. Santra and B. Mukherjee, 2011. Poly [D, L-lactide-co-glycolide] microspheres as a delivery system of protein ovalbumin used as a model protein drug. Trends Applied Sci. Res., 6: 47-56.
22. Sah, H., 1997. Microencapsulation techniques using ethyl acetate as a dispersed solvent: Effects of its extraction rate on the characteristics of PLGA microspheres. J. Control. Rel., 47: 233-245.
23. Sanders, L.M., B.A. Kell, G.I. McRae and G.W. Whitehead, 1986. Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: Influence of composition and molecular weight of polymer. J. Pharm. Sci., 75: 356-360.
24. Segurola, J., N.S. Allen, M. Edge and A. McMahon, 1999. Design of eutectic photoinitiator blends for UV/visible curable acrylated printing inks and coatings. Prog. Org. Coat., 37: 23-37.
25. Singh, D., M. Singh, S. Saraf, V.K. Dixit and S. Saraf, 2010. Formulation optimization of metronidazole loaded chitosan microspheres for wound management by 3-factor, 3-level box-behnken design. Micro and Nanosystems, 2: 70-77.
26. Singh, D., S. Saraf, V.K. Dixit and S. Saraf, 2008. Formulation optimization of gentamicin loaded Eudragit RS100 microspheres using factorial design study. Biol. Pharm. Bull., 31: 662-667.
27. Sung, K.C., R.Y. Han, O.Y.P. Hu and L.R. Hsu, 1998. Controlled release of nalbuphine prodrugs from biodegradable polymeric matrices: Influence of prodrug hydrophilicity and polymer composition. Int. J. Pharm., 172: 17-25.
28. Surini, S., V. Anggriani and E. Anwar, 2009. Study of mucoadhesive microspheres based on pre gelatinized cassava starch succinate as a new carrier for drug delivery. J. Med. Sci., 9: 249-256.
29. WahLy, E.L., F.M. Abdel, S.F. Belal, EA. Heaba and A.E. Kersh, 1995. Simultaneous etermination of enalapril maleate and hydrochlorothiazide by first-derivative ultraviolet spectrophotometry and high-performance liquid chromatography. J. Pharm. Biomed. Anal., 13: 851-856.
30. Warner, N.J. and J.E. Rush, 1988. Safety profiles of the angiotensin-converting enzyme inhibitors. Drugs, 35: 89-97.
31. Yamakawa, I., Y. Tsushima, R. Machida and S. Watanabe, 1992. Preparation of neurotensin analogue-containing poly (dl-lactic acid) microspheres formed by oil-in-water solvent evaporation. J. Pharm. Sci., 81: 899-903.
32. Yoo, Y., D.C. Kim and T.Y. Kim, 1999. Preparation and characterization of enalapril maleate-loaded nanoparticles using amphiphilic diblock copolymers. J. Appl. Polym. Sci., 74: 2856-2867.
33. Zhang, J.X. and K.J. Zhu, 2004. An improvement of double emulsion technique for preparing bovine serum albumin-loaded PLGA microspheres. J. Microencapsulation., 21: 775-785.